Key Findings:  This meta-analysis of therapeutic options for Chron's Disease finds that cannabis is promising, with higher remission rates and potential benefits for disease management. However, there is still a need for larger, standardized research to confirm the benefits and evaluate the risks.
Type of Study:  Meta-analysis
Study Result:  Positive
Research Location(s):  Pakistan
Year of Pub:  2025
Cannabinoids Studied:  Cannabinoid (unspecified)
Phytocannabinoid Source:  Not Applicable
Citation:  Vaid R, Fareed A, Qader R, Hussain A, Shaikh W, Zameer U, Ochani S. Cannabis use in Crohn's disease: a systematic review and meta-analysis of randomized controlled trials (RCTs). Ir J Med Sci. 2025 Jan 17. doi: 10.1007/s11845-024-03844-w. Epub ahead of print. PMID: 39821383.